A Novel Drug, CC-122, Inhibits Tumor Growth in Hepatocellular Carcinoma through Downregulation of an Oncogenic TCF-4 Isoform()()

Immunomodulatory drugs such as lenalidomide (LEN) have shown significant anti-tumor activity against hematologic malignancies and they may have similar actions on solid tumors as well. We studied the effect of a new analog of the immunomodulatory drugs (CC-122) on the growth of hepatocellular carcin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Transl Oncol
Egile Nagusiak: Tomimaru, Yoshito, Aihara, Arihiro, Wands, Jack R., Aloman, Costica, Kim, Miran
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Neoplasia Press 2019
Gaiak:
Original article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6664230/
https://ncbi.nlm.nih.gov/pubmed/31352197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2019.07.002
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak